Response to ASX Aware Letter
Released
Released
Announcement PDF
31 December 2015
ASX Compliance Pty Ltd
Level 40, Central Park
152-158 St Georges Terrace
Attention: Mr Ben Secrett
By email: tradinghaltsperth@asx.com.au
Dear Ben,
Lithium Australia NL (LIT or Entity) ASX AWARE LETTER
Reference is made to your letter dated 24 December 2015 (ASX Aware Letter). Listed below are
the answers to the questions posed. Defined terms in the answer correspond with those defined
terms in the ASX Aware Letter.
1. Does the Entity consider the information disclosed in the Appointment Announcement to
be information that a reasonable person would expect to have a material effect on the
price or value of its securities?
Answer: No
2. If the answer to question 1 is “no”, please advise the basis for that view.
Answer: LIT is of the view that the Appointment Announcement is generally not
information that a reasonable person would expect to have a material effect on the price
or value of its securities as it updates the market as to its previously disclosed strategy in
regard to the LIT / AliX non-binding agreement for the Electra Project. This strategy is
already well known to the market by LIT’s previous releases and periodic reporting.
As advised on 11 November 2015 LIT and TSX:V (AIX) listed company Alix Resources Corp
(Alix) executed a non-binding memorandum of understanding (MOU) to jointly develop
lithium extraction technologies applicable to advancing Alix’s lithium concessions (the
Electra Project) covering 22,625 hectares in Sonora, Mexico. The Electra Project contains
interpreted strike extensions of the Sonora Project, operated by Bacanora Minerals Ltd
(TSXV:BCN,LSE:BCN) and joint venture partner Rare Earth Minerals Plc (LSE:REM). BCN
made headlines when it was announced that a conditional agreement was signed to
supply lithium to Tesla. The deal marked the first much-anticipated raw materials supply
agreement for the electric vehicle manufacturer.
LIT considers the appointment of a consultant is still at a preliminary stage of the
implementation of the strategy. It considers that it is still too early to know if the
appointment will enable the Company to have a significant role to play in supplying
Tesla’s Gigafactory in Nevada (USA).
3. If the answer to question 1 is “yes”, when did the Entity first become aware of the
information disclosed in the Appointment Announcement?
Answer: Not applicable
4. If the answer to question 1 is “yes”, and the Entity first become aware of the information
disclosed in the Appointment Announcement before the Entity received the Price Query
Letter, did the Entity make any announcement prior to the relevant date which disclosed
the information?
Answer: Not applicable
5. Does the Entity consider the information disclosed in the Hydroxide Update to be
information that a reasonable person would expect to have a material effect on the price
or value of its securities?
Answer: Yes
6. If the answer to question 5 is “no”, please advise the basis for that view.
Answer: Not applicable
7. If the answer to question 5 is “yes”, when did the Entity first become aware of the
information disclosed in the Hydroxide Update?
Answer: LIT first became aware of the uninterpreted results forming the basis of the
Hydroxide Update late evening on 21 December 2015. The additional information
announced on 24 December 2015 focuses on the quality of the Lithium Hydroxide
Product. The information, as provided by the laboratory undertaking the work was
incomplete at that time LIT first became aware, and remains incomplete at the date of
this response. Further assays and interpretative analysis is required to determine a
complete mass balance, and hence final recovery. It was therefore considered to be in the
interests of a properly informed market to await such further results (anticipated in the
second week of January 2016) and receive knowledge of the necessary interpretation and
analysis of these results, before making any further announcement on the subject that
could be considered final or definitive. LIT called a trading halt following a discussion with
ASX on 23 December 2015.
The subject of the discussion with ASX concerned possible reasons for the LIT price
increasing from $0.099 on 18 December 2015 to an intra-day high of $0.165 on
Wednesday 23 December 2015 as well as an increase in trading volume. This also
prompted an internal review of work in progress, the anticipation of which may have
been responsible for some of the LIT price movement.
LIT considers that it fully disclosed all information in accordance with Listing Rule 3.1 at
the time of the trading halt and relayed this fact to ASX. LIT still considers this to remain
the position and emphasises that the intermediate results relating to the Hydroxide
Update were only released during the trading halt after further analysis, that was
ongoing, had been completed .
The ability to produce a lithium hydroxide product directly from mica is a significant step
and its achievement was announced on 11 December 2015. That ability creates the
opportunity to tap into a premium product market by producing the highest value lithium
intermediate chemical i.e. lithium hydroxide, as opposed to the lower-priced lithium
carbonate or concentrate. LIT will provide further commentary when final and definitive
results become known to it.
8. If the answer to question 5 is “yes”, and the Entity first become aware of the information
disclosed in the Hydroxide Update before the Entity received the Price Query Letter, did
the Entity make any announcement prior to the relevant date which disclosed the
information? (a) If so, please provide details. (b) If not, please explain why this
information was not released to the market at an earlier time, commenting specifically on
when you believe the Entity was obliged to release the information under Listing Rules 3.1
and 3.1A and what steps the Entity took to ensure that the information was released
promptly and without delay.
Answer: (a) Not applicable. However, please note that an announcement was made on
11 December 2015 that LIT had successfully produced lithium hydroxide which is a
significant value add process and in present markets commands a premium of
approximately 25% to Lithium Carbonate. Currently all other Australian lithium producers
and developers are producing or intend to produce lithium concentrates which require
significant upgrading overseas to produce either Lithium Carbonate or Hydroxide.
Answer: (b) Further details were not released to the market at an earlier time as the
partial uninterpreted results were received late Monday 21 December 2015, the
implication of the results remained unascertained and therefore incomplete, were
confidential and required technical interpretation and review. These results still remain
incomplete and are not definitive at the date of this response. LIT intends to release
further commentary when all assays and analysis have been received.
Whilst the results are preliminary in nature, LIT’s Managing Director, Mr Adrian Griffin,
understood the potential ramifications of these results and considered the materiality of
such results if complete, particularly as they may relate to the Cinovec project, owned by
European Metals Holdings (ASX:EMH) with which LIT has a non-binding Memorandum of
Understanding. As such, it was determined to release what information was in LIT’s
possession to enable the market to form its own assessment of the preliminary
incomplete results and draw their own implications. We maintain that the market cannot
yet determine an informed view especially as the results have only been performed on a
batch process. Furthermore the results indicate it is possible to produce a high quality
lithium hydroxide product from a mica feed source which was previously released to the
market on 11 December 2015. Although this has only been done on a batch process,
integrating the processing step into the technology being used by LIT is likely to produce a
superior outcome, and higher recoveries than competitive processes being used to
produce lithium hydroxide from the more conventional sources, being spodumene (hard
rock) or hydroxide from lithium brines. The reason this is likely to be the case rests in the
complete process circuit design, which remains the subject of IP and confidentiality
agreements.
However it can be said that the processes developed to date are completely compatible
and can be integrated on a continuous basis. It is this integration that provides some of
the most significant processing advantages.
9. LIT hereby confirms that it is in compliance with the Listing Rules and, in particular, Listing
Rule 3.1.
Yours Sincerely
LITHIUM AUSTRALIA NL
Barry Woodhouse
COMPANY SECRETARY
Mobile +61 (0) 438 674 259
Barry.Woodhouse@lithium-au.com
24 December 2015
Barry Woodhouse
Lithium Australia NL
Suite 3, 23 Belgravia Street
BELMONT WA 6104
By email
Dear Mr Woodhouse
LITHIUM AUSTRALIA NL (“ENTITY”): ASX AWARE LETTER
ASX Limited (“ASX”) refers to the following.
1.
The Entity’s announcement entitled “Lithium Australia (ASX: LIT) Appoints KCA for Lithium Clay
Metallurgical Scoping” released on the ASX Market Announcements Platform (“Platform”) at
6.22am AWST on Thursday, 24 December 2015 (the “Appointment Announcement”), disclosing the
appointment of Kappes Cassiday & Associates to commence scoping work on certain of the Entity’s
lithium clay deposits (“Scoping Appointment”).
2.
The price query letter issued to the Entity by ASX on Wednesday, 23 December 2015 (“Price Query
Letter”) and the Entity’s response to the Price Query Letter that was released on the Platform at
6.23am AWST on Thursday, 24 December 2015 (the “Price Query Response”) which stated that:
3.
2.1.
the Entity is not aware of information concerning it that has not been announced to the
market, which if known by some in the market, could explain the recent trading in its
securities;
2.2.
the Entity does not see the Scoping Appointment “as material on its own”; and
2.3.
the Entity “will shortly provide an update for process development work applicable to the
Cinovec Project.”
The Entity’s announcement entitled “Cost Effective Lithium Hydroxide from Mica” released on the
Platform at 6.25am AWST on Thursday, 24 December 2015 (the “Hydroxide Update”) which:
3.1.
discloses the results of laboratory testing of the lithium hydroxide production process from
micas; and
3.2.
states, in respect of the Cinovec Project, that “the ability to produce the value added
hydroxide product, have the potential to double the lithium revenue from that project.”
ASX Compliance
Pty Limited
ABN 26 087 780 489
Level 40, Central Park
152-158 St George's Terrace
Perth WA 6000
www.asx.com.au
Customer service 13 12 79
4.
Listing Rule 3.1, which requires a listed entity to give ASX immediately any information concerning it
that a reasonable person would expect to have a material effect on the price or value of the entity’s
securities.
5.
The definition of “aware” in Chapter 19 of the Listing Rules. This definition states that:
“an entity becomes aware of information if, and as soon as, an officer of the entity (or, in the
case of a trust, an officer of the responsible entity) has, or ought reasonably to have, come
into possession of the information in the course of the performance of their duties as an officer
of that entity.”
Additionally, you should refer to section 4.4 in Guidance Note 8 Continuous Disclosure: Listing Rules
3.1 – 3.1B “When does an entity become aware of information”.
6.
Listing Rule 3.1A, which sets out exceptions from the requirement to make immediate disclosure,
provided that each of the following are satisfied.
“3.1A Listing rule 3.1 does not apply to particular information while each of the following
requirements is satisfied in relation to the information:
3.1A.1 One or more of the following applies:
It would be a breach of a law to disclose the information;
The information concerns an incomplete proposal or negotiation;
The information comprises matters of supposition or is insufficiently
definite to warrant disclosure;
The information is generated for the internal management purposes of
the entity; or
The information is a trade secret; and
3.1A.2 The information is confidential and ASX has not formed the view that the
information has ceased to be confidential; and
3.1A.3 A reasonable person would not expect the information to be disclosed.”
7.
ASX’s policy position on the concept of “confidentiality” which is detailed in section 5.8 of Guidance
Note 8 Continuous Disclosure: Listing Rules 3.1 – 3.1B “Listing Rule 3.1A.2 – the requirement for
information to be confidential”. In particular, the Guidance Note states that:
“Whether information has the quality of being confidential is a question of fact, not one of
the intention or desire of the listed entity. Accordingly, even though an entity may consider
information to be confidential and its disclosure to be a breach of confidence, if it is in fact
disclosed by those who know it, then it ceases to be confidential information for the purposes
of this rule.”
2/5
Having regard to the above, we ask that you answer the following questions in a format suitable for release
to the market in accordance with Listing Rule 18.7A:
1.
Does the Entity consider the information disclosed in the Appointment Announcement to be
information that a reasonable person would expect to have a material effect on the price or value of
its securities?
2.
If the answer to question 1 is “no”, please advise the basis for that view.
3.
If the answer to question 1 is “yes”, when did the Entity first become aware of the information
disclosed in the Appointment Announcement?
4.
If the answer to question 1 is “yes” and the Entity first became aware of the information disclosed in
the Appointment Announcement before the Entity received the Price Query Letter, did the Entity
make any announcement prior to the relevant date which disclosed the information? If so, please
provide details. If not, please explain why this information was not released to the market at an
earlier time, commenting specifically on when you believe the Entity was obliged to release the
information under Listing Rules 3.1 and 3.1A and what steps the Entity took to ensure that the
information was released promptly and without delay.
5.
Does the Entity consider the information disclosed in the Hydroxide Update to be information that a
reasonable person would expect to have a material effect on the price or value of its securities?
6.
If the answer to question 5 is “no”, please advise the basis for that view.
7.
If the answer to question 5 is “yes”, when did the Entity first become aware of the information
disclosed in the Hydroxide Update?
8.
If the answer to question 5 is “yes” and the Entity first became aware of the information disclosed in
the Hydroxide Update before the Entity received the Price Query Letter, did the Entity make any
announcement prior to the relevant date which disclosed the information? If so, please provide
details. If not, please explain why this information was not released to the market at an earlier time,
commenting specifically on when you believe the Entity was obliged to release the information under
Listing Rules 3.1 and 3.1A and what steps the Entity took to ensure that the information was released
promptly and without delay.
9.
Please confirm that the Entity is in compliance with the Listing Rules and, in particular, Listing Rule
3.1.
When and where to send your response
This request is made under, and in accordance with, Listing Rule 18.7. Your response is required as soon as
reasonably possible and, in any event, by not later than noon AWST on Thursday, 31 December 2015. If we
do not have your response by then, ASX will have no choice but to consider suspending trading in the Entity’s
securities under Listing Rule 17.3.
3/5
You should note that if the information requested by this letter is information required to be given to ASX
under Listing Rule 3.1 and it does not fall within the exceptions mentioned in Listing Rule 3.1A, the Entity’s
obligation is to disclose the information “immediately”. This may require the information to be disclosed
before the deadline set out in the previous paragraph.
ASX reserves the right to release a copy of this letter and your response on the ASX Market Announcements
Platform under Listing Rule 18.7A. Accordingly, your response should be in a form suitable for release to the
market.
Your response should be sent to me by e-mail at tradinghaltsperth@asx.com.au. It should not be sent
directly to the ASX Market Announcements Office. This is to allow me to review your response to confirm
that it is in a form appropriate for release to the market, before it is published on the ASX Market
Announcements Platform.
Listing Rule 3.1
Listing Rule 3.1 requires a listed entity to give ASX immediately any information concerning it that a
reasonable person would expect to have a material effect on the price or value of the entity’s securities.
Exceptions to this requirement are set out in Listing Rule 3.1A.
The obligation of the Entity to disclose information under Listing Rules 3.1 and 3.1A is not confined to, nor is
it necessarily satisfied by, answering the questions set out in this letter.
In responding to this letter, you should have regard to the Entity’s obligations under Listing Rules 3.1 and
3.1A and also to Guidance Note 8 Continuous Disclosure: Listing Rules 3.1 – 3.1B.
Trading halt
If you are unable to respond to this letter by the time specified above, you should discuss with us whether it
is appropriate to request a trading halt in the Entity’s securities under Listing Rule 17.1.
If you wish a trading halt, you must tell us:
the reasons for the trading halt;
how long you want the trading halt to last;
the event you expect to happen that will end the trading halt;
that you are not aware of any reason why the trading halt should not be granted; and
any other information necessary to inform the market about the trading halt, or that we ask for.
4/5
We may require the request for a trading halt to be in writing. The trading halt cannot extend past the
commencement of normal trading on the second day after the day on which it is granted.
You can find further information about trading halts in Guidance Note 16 Trading Halts & Voluntary
Suspensions.
Please contact me if you have any queries or concerns about the above.
Yours sincerely
[sent electronically without signature]
Ben Secrett
Senior Adviser, ASX Listings Compliance
5/5
Share your feedback
Discover